Supply Chain | September 28, 2021
SpeeDx and SynGenis partner for custom oligonucleotide synthesis
The investment will increase SpeeDx internal capacity to scale up manufacturing
The investment will increase SpeeDx internal capacity to scale up manufacturing
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.
Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
These aprons utilise phase change materials that absorb, store and release heat for optimal thermal comfort
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
Subscribe To Our Newsletter & Stay Updated
